SCHEMBL18985165

SCHEMBL18985165

Cc1cc(OC(=O)c2ccc(OCCCCCCO[Si](C(C)C)(C(C)C)C(C)C)cc2)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
NPC1 O15118 3/20 0.46
NFKB1 P19838 3/20 0.46
NFKB2 Q00653 3/20 0.46
RELA Q04206 3/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
GAA P10253 1/20 0.41
NR1H4 Q96RI1 2/20 0.40
POLB P06746 1/20 0.40
PRSS1 P07477 1/20 0.39
ACR P10323 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6679861 0.83 NPC1 (0.61) LMNANPC1NFKB1NFKB2RELA
SCHEMBL29783189 0.82 PPARG (0.42) LMNANPC1NFKB1NFKB2RELA
SCHEMBL18985175 0.82 PPARG (0.42) LMNANPC1NFKB1NFKB2RELA
SCHEMBL29783272 0.81 NR1H4 (0.47) LMNAMAPTKMT2AGAANR1H4
SCHEMBL18985158 0.81 NR1H4 (0.47) LMNAMAPTKMT2AGAANR1H4
SCHEMBL18985174 0.80 KDM4E (0.41) LMNANPC1NFKB1NFKB2RELA
SCHEMBL19027823 0.80 MAPT (0.62) NPC1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL18985161 0.78 KDM4E (0.39) LMNANPC1NFKB1NFKB2RELA
SCHEMBL12794264 0.77 NPC1 (0.45) LMNANPC1NFKB1NFKB2RELA
SCHEMBL18985168 0.77 TP53 (0.63) GAAPOLBTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108368425-B Liquid crystal mixture and liquid crystal display 默克专利股份有限公司(DE) 2023-01-13 CN disclosed
CN-114702965-A Liquid crystal mixture and liquid crystal display 默克专利股份有限公司 2022-07-05 CN disclosed
US-20220106525-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2022-04-07 US disclosed
EP-3864111-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2021-08-18 EP disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
CN-112805353-A Liquid crystal mixture and liquid crystal display 默克专利股份有限公司 2021-05-14 CN disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
EP-3390570-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-03-18 EP disclosed
EP-3390570-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2018-10-24 EP disclosed
WO-2017102068-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed
WO-2017102068-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106525-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY CXCR1, PYM1, F11 LMNA 1207/4885NPC1 345/4885NFKB1 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.